Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IkonisysXPAR:ALIKO -0.68%65 FCF Margin % is 0.00% as of Jun. 2025. GuruFocus rates XPAR:ALIKO with a GF Score™ of 65/100 and a GF Value™ of €3.76 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 814 Medical Devices & Instruments companies, Ikonisys ranks worse than 122850% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Ikonisys's Free Cash Flow for the
six
months ended in Jun. 2025 was €0.00 Mil. Ikonisys's Revenue for the
six
months ended in Jun. 2025 was €0.75 Mil. Therefore, Ikonisys's FCF Margin % for the quarter that ended in Jun. 2025 was 0.00%.
The historical rank and industry rank for Ikonisys's FCF Margin % or its related term are showing as below:
During the past 7 years, the highest FCF Margin % of Ikonisys was -135.21%. The lowest was -394.29%. And the median was -326.09%.
XPAR:ALIKO's FCF Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -0.72 * Ranked among companies with meaningful FCF Margin % only.
The historical data trend for Ikonisys's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:ALIKO vs ABT, SYK, MDT: FCF Margin % Comparison
For the Medical Devices subindustry, Ikonisys's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ikonisys FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ikonisys's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Ikonisys's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ikonisys (XPAR:ALIKO) has a FCF Margin % of 0.00% as of Jun. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Ikonisys and its competitors. According to the industry distribution chart, Ikonisys ranks #999999 out of 814 companies in the Medical Devices & Instruments industry.
Is Ikonisys' FCF Margin % too high?
Ikonisys' current FCF Margin % is 0.00%. Based on the distribution chart, Ikonisys ranks #999999 out of 814 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Ikonisys has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ikonisys' FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ikonisys ranks #999999 out of 814 companies for FCF Margin %. This places Ikonisys in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Ikonisys and its competitors. Ikonisys's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ikonisys stock overvalued right now?
Based on GuruFocus' analysis, Ikonisys (XPAR:ALIKO) is currently considered Possible Value Trap. The stock's GF Value™ is €3.76, compared to a current price of €1.45 — trading 61.4% below its estimated fair value. The current FCF Margin % is 0.00%. Ikonisys' overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Ikonisys (XPAR:ALIKO), the current FCF Margin % is 0.00% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ikonisys (XPAR:ALIKO) Overvalued in 2026?
Based on GuruFocus' analysis, Ikonisys stock appears to be undervalued.
The current stock price of €1.45 is trading 61.4% below its estimated GF Value™ of €3.76.
GuruFocus considers Ikonisys to be Possible Value Trap.
Key valuation signals for XPAR:ALIKO:
FCF Margin %: 0.00%
GF Value™: €3.76 vs. price of €1.45 (61.4% below fair value)
No single metric tells the full story. See the XPAR:ALIKO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ikonisys SA specializes in the design, manufacture, and marketing of medical diagnostic equipment. The company offers cell diagnostic products in the fields of cancer diagnosis, detection of genetic disorders, and fertility testing.
65GF Score
Get the complete analysis for XPAR:ALIKO
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:ALIKO has been successfully added to your 
